Skip to main content

Advertisement

Fig. 3 | Clinical Proteomics

Fig. 3

From: Differential Plasma Glycoproteome of p19ARF Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform

Fig. 3

Correlation between LC elution times for MS/MS identified peptides using an LTQ-FT platform versus their respective LC-MS aligned features from an ESI-TOF platform. Shown are 48 MS/MS identified peptides from the analysis of one mouse plasma glycopeptide isolate that could be mapped back onto the LC-MS data. Both instruments use a similar HPLC hardware setup, and all 48 features were validated by visual examination of the original raw data files

Back to article page